RÉSUMÉ DIGEST
ACT 416 (SB 94) 2023 Regular Session Kleinpeter
Existing law provides for mitragynine speciosa to be added to the Uniform Controlled
Dangerous Substances Law. Prior law further provides that the schedule to which the
substance will be added is dependent upon the classification of the substance as a controlled
dangerous substance by the federal Drug Enforcement Administration.
New law repeals prior law.
New law creates the crime of unlawful sale or distribution of mitragynine speciosa to
persons under the age of 21, which provides that no person can sell or distribute, or cause
to be sold or distributed, a product containing mitragynine speciosa to any person under the
age of 21. New law further defines "mitragynine speciosa" as a product containing either or
both of the following: (1) Mitragynine; (2) 7-Hydroxy-mitragynine.
New law provides that whoever violates new law will be fined up to $500, imprisoned for
up to six months, or both.
New law creates the "Local Option for Mitragynine Speciosa," which authorizes local
governments to enact ordinances to prohibit the sale or distribution of mitragynine speciosa
products or to regulate the sale or distribution of such products in a more restrictive manner
than new law.
Effective August 1, 2023.
(Adds R.S. 14:91.10 and R.S. 40:1300.51-1300.53; repeals Act No. 231 of the 2019 R.S.)


Statutes affected:
SB94 Enrolled:
SB94 Act :